Abstract: Embodiments provided herein include CPR assisting devices. Certain embodiments pertain to a device that may be adhered to patient's chest to aid in active compression/decompression CPR. The device may be incorporated with the AED pad for implementation in conjunction with defibrillator machine.

Abstract: A method and related system for providing therapy to a treatment site, such as stenosis or other vasculature disease, at one or more locations of a subject, such as the vasculature. The method includes: advancing an ultrasound catheter to or in proximity to the subject's treatment site; infusing microbubbles into or proximal to the treatment site; and delivering ultrasonic energy from the ultrasound catheter. The ultrasonic energy may be adapted for: imaging the treatment site, translating the microbubbles into or in the vicinity of the treatment site and/or rupturing the microbubbles.

Abstract: Compounds which modulate quorum sensing in quorum sensing bacteria. Compounds of the invention inhibit quorum sensing and/or activate quorum sensing in various bacteria. Compounds that inhibit quorum sensing are particularly useful for inhibition of detrimental bacterial biofilm formation. Compounds that activate quorum sensing are particularly useful for promoting growth and biofilm formation of beneficial bacterial.

Abstract: Devices and systems for power electronic circuits are provided. Embodiments of the present invention enable high density inductive energy storage by using electromechanical coupling between an electrically conducting inductive element and a mechanical resonator to passively store energy via both electromagnetic and mechanical mechanisms. A microelectromechanical inductor (MEMI) is provided utilizing a magnet and a conductor. In a specific embodiment, the MEMI includes a permanent magnet on a compliant layer centrally disposed within a spiral coil. In a further embodiment, a second coil is provided near the magnet to provide a resonating transducer.

Abstract: There are provided an apparatus and a method for establishing a contention window in a WiMedia wireless network. The contention window establishing apparatus includes: a parsing unit extracting the number of devices that intend to transmit data from a beacon received during a beacon period and an access category (AC) of each device; a calculation unit calculating a transmission probability of each access category (AC) on the basis of the extracted number of devices; and a contention window establishing unit establishing a contention window for each access category (AC) on the basis of the calculated transmission probability, to reduce contentions among the devices and decrease data transmission latency time, thereby maximizing efficiency in data transmission latency time.

Abstract: This invention relates to altered forms of members of the RNase A superfamily. An RNase A can be modified to be cytotoxic by altering its amino acid sequence so that it is not bound easily by the ribonuclease inhibitor while still retaining catalytic properties. While earlier work had identified some modifications to RNase A that would result in cytotoxicity, the use of the FADE algorithm for molecular interaction analysis has led to several other locations that were candidates for modification. Some of those modifications did result in RNase A variants with increase cytotoxicity.

Abstract: Provided is a secondary battery comprising a positive electrode active material represented by the following Chemical Formula 1, Li{LiaMnxM1-a-x-yM?y}O2 ??[Chemical Formula 1] where 0<a?0.2, x>(1-a)/2, and 0<y<0.2(1-a), and M is simultaneously applied by any one element or two or more elements selected from the group consisting of group 3 and 4 elements, and M? is a metal having an ion diameter of 70 pm or more with an oxidation number of 4 as well as a six-coordinate octahedral structure (specifically, any one element or two or more elements selected from the group consisting of titanium (Ti), vanadium (V), and iron (Fe) are simultaneously applied). According to the present invention, a high capacity lithium secondary battery having improved safety and processability may be provided.

Abstract: Provided is a battery exchanging type charging station system for an electric vehicle. The battery exchanging type charging station system includes a charging station body formed with a structure in which the electric vehicle freely enters and exits and including a battery loading unit for receiving the battery, a battery replacing robot mounted in the charging station body to perform a battery replacement operation, a charging station control unit to control the battery replacing robot such that the battery replacement operation is performed by controlling the battery replacing robot, an information recognition unit configured to obtain data on an electric vehicle that enters the charging station body and/or data on a type, size, charging state, release date, charging date or the like of the battery, and a charging station control unit that allows a replacement operation of the battery to be performed by controlling the battery replacing robot.

Abstract: A method of fabricating a liquid for an oxide thin film is provided, which includes mixing at least two kinds of dispersoids selected from the group consisting of a Zinc compound, an Indium compound, a Gallium compound, a Tin compound and a Thallium compound, with dispersion media corresponding to the selected dispersoids to form a dispersion system, and stirring and aging the dispersion system at a predetermined temperature for a predetermined time, wherein a molar ratio of the Zinc compound to each of the Indium compound, Gallium compound, Tin compound and Thallium compound is 1:0.1 to 1:2. According to the present invention, the liquid for the oxide thin film may be fabricated by a sol-gel method making it capable of being implemented in mass production in a simple and low-cost manner as opposed to the conventional vacuum deposition method.

Abstract: The invention provides for compositions and methods for producing plants that have higher yield in drought conditions by manipulating the G-proteins such as the rice alpha subunit gene, RGA1.

Abstract: A HA-gelatin-pluronic hydrogel and a method for making a HA-gelatin-pluronic hydrogel are provided. The hydrogel includes hyaluronic acid, gelatin-Type A and a thermoreversible, hydrophilic non-ionic surfactant gel. The thermoreversible, hydrophilic non-ionic surfactant gel can be a poly(ethylene oxide)99-poly(propylene oxide)67-poly(ethylene oxide)99 (“Pluronic F127”). The weight ratio of HA to gelatin-Type A is between 1:2 and 2:1 and preferably about 1:1. The weight ratio of HA and gelatin-Type A to thermoreversible, hydrophilic non-ionic surfactant gel is between 1:3,000 and 1:150, preferably between 1:3,000 and 1:600 and most preferably about 1:2,400. The hydrogel is formed by combining hyaluronic acid and gelatin-Type A to form a solution, cooling the solution, mixing the solution with Pluronic F127 to form a mixture and storing the mixture at a temperature of from 25° C. to 45° C. preferably about 37° C.

Abstract: The invention provides a method of isolating one or more compounds present in fruit juice or seed extracts that have anti-microbial activity.

Abstract: The present invention provides enriched polynucleotides, and enriched polypeptides having pectinase activity. The present invention also includes methods of using the polynucleotides and polypeptides described herein.

Abstract: The invention relates to therapy and methods of applying the therapy to cancer patients. The invention includes introducing intratumorally cytotoxic T lymphocyte and/or NKT cells, and prior to, coincident with, or following introducing intratumorally the cytotoxic T lymphocyte and/or NKT cells, introducing intratumorally anti-TNF and/or anti-IL-10 to the patient. The cytotoxic T lymphocyte and/or NKT cells can be induced by the intratumoral introduction of immature dendritic cells to the patient This therapy of the invention can be effective to regress, reduce or eliminate tumor cells in tumor tissue of the patients in the absence of radiation therapy.

Abstract: An edible composition of matter having an apparent viscosity of from about 150 cP to about 2000 cP at about 30 s?1; a yield stress of from 0 Pa to about 20 Pa at 1 s?1; and a flow index of from about 0.2 to about 0.6. The composition may include an imaging agent. The compositions are useful for providing sustenance to dysphagic subjects and for evalualuating dysphagia.

Abstract: The invention relates to an implantable device fixed or interlinked to bone, which generates unidirectional movement by a member generating reciprocating motion in the same direction using means allowing unidirectional movement. In the device, the means allowing unidirectional movement comprise means based on friction which make line contact.

Abstract: A search of the public human genome database identified a human EST, GenBank accession number AW293249, which has high homology to known pufferfish urocortin sequences. The full length sequence was amplified from human genomic DNA and sequenced. Sequence homology comparisons of the novel sequence with human urocortin I and urocortin II revealed that the sequence encoded a novel human urocortin, which was designated urocortin III (UcnIII). While urocortin III does not have high affinity for either CRF-R1 or CRF-R2, the affinity for CRF-R2 is greater than the affinity for CRF-R1. Urocortin III is capable stimulating cyclic AMP production in cells expressing CRF-R2? or ?. Thus, the affinity is high enough that urocortin III could act as a native agonist of CRF-R2. However, it is also likely that urocortin III is a stronger agonist of a yet to be identified receptor.

Abstract: The present application discloses a system for controlling the operation of a microgrid that includes a power unit configured to include a distributed power source including one or more new and renewable energy power sources and to convert the power of the distributed power source and supply the converted power to a load, a load calculation unit configured to calculate an optimal output condition according to the type of load included in a load list in response to the signal of an external power generation source.

Abstract: This invention provides methods for treatment and inhibition of a male subject having an Androgen Decline in Aging Male (ADAM)-associated condition, for example sexual dysfunction, decreased sexual libido, erectile dysfunction, hypogonadism, sarcopenia, osteopenia, osteoporosis, an alteration in cognition and mood, depression, anemia, hair loss, obesity, muscle loss, dry eye, memory loss, benign prostate hyperplasia and/or prostate cancer, by administering to the subject a selective androgen receptor modulator (SARM) compound and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, pro-drug, polymorph, crystal, or any combination thereof.

Abstract: The variety ‘T-959’ ripens around the first week of June in southern Georgia. The fruits of the new ‘T-959’ variety are very large, firm, and have good flavor. The new ‘T-959’ variety is vigorous with an estimated chilling requirement of about 500 to 550 hours at or below approximately 7° C. The new variety is reliably propagated vegetatively.